| CONTENTS | |||
|---|---|---|---|
| Page | |||
| Trustees' Report |
1-3 | ||
| Independent Examiner's |
Report | ||
| Statement of Financial Activities | |||
| Balance Sheet | |||
| Notes to the Financial Statements | 7-10 | ||
| Schedule of Investments | 11-14 |
| Unrestricted | fund | ||||
|---|---|---|---|---|---|
| Note | 2023 | 2022 | |||
| f | f | ||||
| Income and endowments: | |||||
| Investments: | |||||
| Income from investments | 46,254 | 38,218 | |||
| Total income and endowments | 46,254 | 38,218 | |||
| Expenditure | |||||
| Costs ofraising funds: | |||||
| Investment management |
fees | 14,540 | 16,453 | ||
| Expenditure on charitable |
activities: | ||||
| Direct charitable donations |
5 | 70,000 | 30,000 | ||
| Governance costs |
6 | 7,234 | 4,812 | ||
| Total expenditure | 90,474 | 51,265 | |||
| Net expenditure | (44,220) | (13,047) | |||
| Other recognised gains/(losses): | |||||
| Unrealised gains/(losses) |
on revaluation | (50,395) | 107,663 | ||
| Realised gains/(losses) on |
disposals | 1,050 | 6,333 | ||
| Net gains/(losses) on investment |
assets | (49,345) | 113,996 | ||
| Net movement in funds |
(94,865) | 100,949 | |||
| Reconciliation of'funds |
|||||
| Funds brought forward |
9 | 2,347,811 | 2,246,862 | ||
| Funds carried forward | 9 | 2,252,946 | 2,347,811 |
| Income from | Income from | investments | 2023 | 2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| f | f | |||||||||
| Investments | listed on |
a | recognised | stock | exchange | or | ||||
| consisting | of | collective investments: | ||||||||
| Dividends | 37,011 | 31,068 | ||||||||
| Dividends | from overseas | companies | and | unit | trusts | 9,243 | 7,150 | |||
| 46,254 | 38,218 |
| 5. | Direct charitable institutional |
Direct charitable institutional |
grants | grants | |||||
|---|---|---|---|---|---|---|---|---|---|
| The following grants were made | in the year. | ||||||||
| 2023 | 2022 | ||||||||
| f | f | ||||||||
| Silsden Aid ln Sickness | Fund (Registered | Charity: | No 236399) | 70,000 | 30,000 | ||||
| 70,000 | 30,000 | ||||||||
| 6. | Governance costs |
||||||||
| 2023 | 2022 | ||||||||
| f | f | ||||||||
| Legal and professional | fees (note 10) | 5,934 | 3,678 | ||||||
| Accountancy and Independent |
Examination | (note 3) | 1,300 | 1,134 | |||||
| 7,234 | 4,812 | ||||||||
| 7. | Investments | 2023 f |
2022 f |
||||||
| Market value brought | forward | 2,357,935 | 2,256,012 | ||||||
| Add: additions to investments | at cost | 152,699 | 96,908 | ||||||
| Less: opening cash |
(169,675) | (167,692) | |||||||
| Disposals at carrying | value | (200,174) | (104,631) | ||||||
| Unrealised gain/(loss) |
on revaluation | (50,395) | 107,663 | ||||||
| Cash awaiting re-investment |
168,392 | 169,675 | |||||||
| Market value carried | forward | 2p258,782 | 2,357,935 | ||||||
| At historic cost at 5 April | 1,801,946 | 1,754,541 |
| 2023 | 2022 | ||
|---|---|---|---|
| f | E | ||
| UK equities | 1,667,290 | 1,720,540 | |
| Overseas equities | 423,100 | 467,720 | |
| Cash awaiting | re-investment | 168,392 | 169,675 |
| 2,258,782 | 2,357,935 |
| Accruals | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|
| f | f | ||||||
| Investment | portfolio management | fees | 0 | 4,400 | |||
| Accountancy | and independent | examination | 1,300 | 1,140 | |||
| Wrigleys | law | advice | 4,536 | 4,920 | |||
| 5,836 | 10,460 |